| abstract |
Compounds that antagonize the vasopressin receptor, particularly V1a receptor products containing the compounds, and methods of their use and synthesis are provided. The compound, or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, has the structure of formula (I), and in the formula, Q 1 , Q 2 , Q 3 , R 2a , R 2b , R 3 , and X are as defined herein. |